Ahmad Alikhani
- Infectious Diseases top 5%
- Molecular Biology
- Parasitology top 5%
- Neurology top 10%
- Epidemiology
- Co-authors
- Jay D. KeaslingDavid L. ShisJeffrey A. DietrichWilliam BowieCorinne OngJ. Bruce TomblinJudith L. Isaac‐RentonDiane Eisler
- Topics
- COVID-19 Clinical Research Studies (5 papers)Pneumonia and Respiratory Infections (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsSmall
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Ahmad Alikhani
44 papers receiving 890 citations
Peers
Comparison fields: 5 of 117
- Infectious Diseases 309
- Molecular Biology 262
- Parasitology 169
- Neurology 143
- Epidemiology 143
Countries citing papers authored by Ahmad Alikhani
This map shows the geographic impact of Ahmad Alikhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Alikhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Alikhani more than expected).
Fields of papers citing papers by Ahmad Alikhani
This network shows the impact of papers produced by Ahmad Alikhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Alikhani. The network helps show where Ahmad Alikhani may publish in the future.
Co-authorship network of co-authors of Ahmad Alikhani
This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Alikhani. A scholar is included among the top collaborators of Ahmad Alikhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Alikhani. Ahmad Alikhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | Efficacy of new treatment modalities in patients with covid-19, qaemshahar razi hospital 2020 | 1 |
| 5 | 2 | |
| 6 | 20 | |
| 7 | 43 | |
| 8 | 16 | |
| 9 | 13 | |
| 10 | Sero-Epidemiological Study of Leptospirosis in Healthy People in Qaemshahr, Iran, 2015 | 3 |
| 11 | 36 | |
| 12 | 81 | |
| 13 | Epidemiological Study, Risk factors and Clinical Outcomes of Diabetic Foot Infection in Hospitalized Patients | 2 |
| 14 | The Awareness of General Practitioners of Mazandaran Province to Diagnosis, Treatment and Prevention of Cholera | 0 |
| 15 | 1 | |
| 16 | 20 | |
| 17 | 23 | |
| 18 | 7 | |
| 19 | Survey on Antibiotic Prescription for under 14 Years Old Outpatient Children in General Practitioner Prescriptions in Yasuj | 1 |
| 20 | 1 |
About Ahmad Alikhani
Ahmad Alikhani is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Parasitology, having authored 48 papers that have together received 912 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Pneumonia and Respiratory Infections (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Parasitology (169 citations), Infectious Diseases (309 citations) and Neurology (143 citations). Ahmad Alikhani has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Jay D. Keasling, David L. Shis, Jeffrey A. Dietrich, William Bowie, Corinne Ong, J. Bruce Tomblin, Judith L. Isaac‐Renton, Diane Eisler, Vincent Fung and Farhang Babamahmoodi. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.